Search Results

Gregory Tall About Dr. Gregory Tall " Dr. Gregory Tall earned his Ph.D. in Biomedical Sciences from U.T. Gregory Tall on the web The Tall Lab University of Michigan Google Scholar Twitter Dr.

Trained as a biochemist, he completed a PhD in protein engineering (Cambridge, UK) with Sir Gregory Winter

Pan, Michael Holinstat and Gregory G. Gregory Tall and our research primarily focuses on the structural and biochemical characterization of

gpcrs-in-cardiology-endocrinology-and-taste/latrophilin-2-deletion-in-cardiomyocyte-disrupts-cell-junction%2C-leading-to-d-cmp

Created a durable innovation hub This is more than a story — it’s a blueprint for GPCR science, biotech R&D,

behind pH Sense, Revvity’s innovative GPCR internalization assay, and his journey in GPCR product R&D. Eric Trinquet is Head of R&D for Life Sciences Reagents at Revvity, where he leads innovation in biochemical

Pharmacology #DrugDiscovery #AllostericModulation #Kinetics #AssayDevelopment #EarlyDiscovery #PharmaR&D

discovery company focused on targeting GPCR heteromers in cancer, headquartered in Seoul, Korea, with an R&D

In particular, she is looking at L- and D-lactate-activated HCAR1 signaling.

#DrugDiscovery #Biotech #AllostericModulation #Kinetics #AssayDevelopment #EarlyDiscovery #PharmaR&D

Leipzig, Germany 2 Institute of Medical Physics and Biophysics, Leipzig University, Härtelstr. 16-18, D- Rudolf-Schönheimer-Institute of Biochemistry, Division of General Biochemistry, Leipzig University, Johannisallee 30, D- Rudolf-Schönheimer-Institute of Biochemistry, Division of Molecular Biochemis-try, Leipzig University, Johannisallee 30, D-

Yamina Berchiche on the web D r.

His Ph.D. work has been focused on understanding the structure and activation of Class D fungal GPCRs

Following this, he joined an early-stage medical device start-up and in 5 years was responsible for project R&D and managing a focused development team, pursued international strategic partnerships, managed IP

I work with invertebrate animal models (mainly D. melanogaster) and in vitro techniques to pick apart

I have 10 years of experience in the development and management of R&D projects and teams in the field Sciences from the University of Lausanne, Switzerland, Department of Biochemistry (2005-2009), where I started And since then, my incredible adventure as CEO of this fast-growing company started and is continuing

In 2005 he started working on the development of conformational thermostabilization of GPCRs, which resulted of a GPCR bound to a biased agonist and coupled to arrestin and also the first structure of a Class D

He also directs a collaborative neuroscience R&D program with Servier (France) and is the co-founder

to the GPCR field , including: Academic researchers (PI, postdoc, student) Industry scientists and R&D

Optimized CRO Collaboration: Streamline internal R&D and external CRO workflows to prevent delays and focused execution accelerates preclinical milestones and maximizes the efficiency and return on your R&D

, Kim JH, Jeong K, Murphy JM, Harvey CA, Dunlap S, Gehrs L, Lee H, Kim HG, Sah JP, Lee SN, Stanford D, Two major types of mRNAs were identified in human/mouse brain, those with a start codon in exon 2 encoding a full-length protein of a predicted size of 173.5/173.3 kDa and shorter transcripts starting from alternative exons at the intron 17/exon 18 boundary with new or exon 19 start codons, predicting shorter isoforms Attendees Authors & Affiliations "Gandhi, Riya; Chandan, Nancy; Kwarcinski, Frank; Smrcka, Alan; and Tall, Gregory

Stuart Maudsley About Dr. Stuart Maudsley Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree Upon starting a new family, and returning to Europe, Dr. Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook

Stuart Maudsley About Dr. Stuart Maudsley Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree Upon starting a new family, and returning to Europe, Dr. Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook

Stuart Maudsley About Dr. Stuart Maudsley Stuart graduated from the University of Leeds in the U.K. with a First Class Honors degree Upon starting a new family, and returning to Europe, Dr. Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook

chemists and structural biologists Early-career researchers exploring drug discovery Biotech leaders and R&D

Revvity, Eric worked for Cisbio Bioassays first as Director of Technological Development and then as R&D Elodie DUPUIS R&D Senior project manager, team leader.

He works in a multidisciplinary Chemical Biology team based at the recently established US R&D hub in

My experience in basic research at several universities worldwide and early R&D at Novo Nordisk A/S allowed me to shape a swiss start-up company from a scientifc idea to a thriving Biotech focusing on Systems

Kwarcinski, Gregory G. Mariam started her postdoctoral training in February 2024 and is hoping to become an academic professor

Home → Flash News → A GPCR imaging breakthrough that didn’t start in a grant proposal A GPCR imaging breakthrough that didn’t start in a grant proposal Published on December 3, 2025 Category It started